RenovoRx, Inc. (RNXT)
NASDAQ·Healthcare·Biotechnology
$0.85
-2.88%
Mkt Cap $29.33M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 30, 2026 | $419.70K | $238.00K | -43.29% | -$0.08 | -$0.08 | +0.00% | — | — |
| Q4 2025 Nov 13, 2025 | $405.40K | $266.00K | -34.39% | -$0.08 | -$0.08 | +0.00% | — | — |
| Q3 2025 Aug 14, 2025 | $304.00K | $422.00K | +38.82% | -$0.08 | -$0.08 | +0.00% | — | — |
| Q2 2025 May 15, 2025 | $183.33K | $197.00K | +7.46% | -$0.08 | -$0.08 | +0.00% | — | — |
| Q1 2025 Mar 31, 2025 | $167.50K | $43.00K | -74.33% | -$0.13 | -$0.12 | +7.69% | — | — |
| Q4 2024 Nov 13, 2024 | — | — | — | -$0.12 | -$0.10 | +16.67% | — | — |
| Q3 2024 Aug 13, 2024 | — | — | — | -$0.10 | -$0.10 | +0.00% | — | — |
| Q2 2024 May 10, 2024 | — | — | — | -$0.14 | -$0.07 | +50.00% | — | — |
| Q2 2024 Apr 1, 2024 | — | — | — | -$0.30 | -$0.17 | +43.33% | — | — |
| Q4 2023 Nov 13, 2023 | — | — | — | -$0.30 | -$0.27 | +10.00% | — | — |
| Q3 2023 Aug 16, 2023 | — | — | — | -$0.25 | -$0.22 | +12.00% | — | — |
| Q2 2023 May 15, 2023 | — | — | — | -$0.25 | -$0.36 | -44.00% | — | — |
| Q1 2023 Mar 2, 2023 | — | — | — | -$0.26 | -$0.23 | +11.54% | — | — |
| Q4 2022 Nov 14, 2022 | — | — | — | -$0.27 | -$0.24 | +11.11% | — | — |
| Q3 2022 Aug 15, 2022 | — | — | — | -$0.26 | -$0.29 | -11.54% | — | — |
| Q2 2022 May 16, 2022 | — | — | — | -$0.25 | -$0.33 | -32.00% | — | — |
| Q1 2022 Mar 30, 2022 | — | — | — | -$0.18 | -$0.12 | +33.33% | — | — |
| Q4 2021 Nov 15, 2021 | — | — | — | -$0.21 | -$0.27 | -28.57% | — | — |
| Q3 2021 Aug 27, 2021 | — | — | — | — | -$0.08 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$0.07 | — | — | — |